Oligodendrogliomas: Reproducibility and Prognostic Value of Histologic Diagnosis and Grading

Prognostic value of histological grading of oligodendroglial tumors is controversial and interobserver reproducibility in grading of these tumors is unknown. Seven neuropathologists and 6 surgical pathologists experienced in brain tumor diagnosis assessed 124 oligodendroglial tumors operated at the Mayo Clinic (1960–1990). Among histologic parameters upon which current oligodendroglioma grading systems are based, only high cellularity, presence of mitoses, microcalcifications, endothelial hypertrophy, endothelial proliferation, and necrosis appeared to be reproducible. Reproducible histologic features, based on consensus ratings among neuropathologists (defined as >60%), were evaluated for the association with cause-specific survival by fitting Cox regression models. By univariate analysis, a significant association with survival was found for age, high cellularity, presence of mitoses, endothelial hypertrophy and proliferation and necrosis. On multivariable analysis with a stepwise variable selection method, only age and presence of endothelial proliferation were found to be independently associated with survival with a discriminatory index of the model of 0.68. Mitotic index was significantly associated with survival based on the grading from each separate neuropathologist, but it was not based on consensus, most likely because this was classified as indeterminate in 54% of cases. Alternatively, “models fit” considering the assessment of single neuropathologists, identified a model based on age and on mitotic index with similar discriminatory indices of 0.69–0.7. Our study found few factors independently associated with cause specific-survival among morphological parameters. These findings are consistent with the present WHO stratification of oligodendrogliomas into low- and high-grade variants.

[1]  D. Louis,et al.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.

[2]  R. McLendon,et al.  Clinicopathologic correlations in the oligodendroglioma , 1987, Cancer.

[3]  S. Coons,et al.  The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. , 1997, Neurosurgery.

[4]  D. Troost,et al.  Oligodendroglioma. A comparison of two grading systems , 1988, Cancer.

[5]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[6]  B. Scheithauer,et al.  Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.

[7]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[8]  G. Eide,et al.  Oligodendroglioma. Histologic Evaluation and Prognosis , 1986, Journal of neuropathology and experimental neurology.

[9]  J. Kros,et al.  Prognostic value of the proliferation‐related antigen Ki‐67 in oligodendrogliomas , 1996, Cancer.

[10]  B. Scheithauer,et al.  Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.

[11]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  V. Armbrustmacher,et al.  Grading of oligodendrogliomas , 1983, Cancer.

[13]  M. Brada Pathology and Genetics of Tumours of the Nervous System , 2001, British Journal of Cancer.

[14]  H. Korf,et al.  Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases , 1998, Acta Neuropathologica.

[15]  D K Pearl,et al.  Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.

[16]  A. Bowker,et al.  A test for symmetry in contingency tables. , 1948, Journal of the American Statistical Association.

[17]  B. Scheithauer,et al.  Histological Classification of Tumours of the Central Nervous System , 1993 .

[18]  P. Bailey,et al.  Oligodendrogliomas of the brain , 1929 .

[19]  G. Fuller,et al.  Diagnostic discrepancies and their clinical impact in a neuropathology referral practice , 1997, Cancer.

[20]  L. Rorke Pathologic diagnosis as the gold standard , 1997, Cancer.

[21]  R. Mccomb,et al.  Pathology and Genetics of Tumours of the Nervous System , 1998 .

[22]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[23]  O. G. Dodge,et al.  Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.

[24]  S. Coons,et al.  Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas. , 1994, Neurosurgery.

[25]  A. Poustka,et al.  Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System Tumors , 2000, Journal of neuropathology and experimental neurology.

[26]  Michael F Gonzales,et al.  Grading of gliomas , 1997, Journal of Clinical Neuroscience.